採用
Job Description:
【職務概要】
・担当疾患領域における情報を基に、Scientific Leader(SL)/Key Decision Maker(KDM)と科学的交流を行い信頼関係を構築する。
・MSL活動で得られた情報を、社内ステークホルダーと共有する。
・Medical Strategy(CMAP)/Field Engagement Plan(FEP)に基づくIndividual Planの作成・実行
【主な業務】
・FM-SOP、厚生労働省の医療用医薬品の販売情報提供ガイドラインなどの社内外の規制に沿った、SL/KDMとのScientific Exchange
・SL/KDMの依頼に応じた、科学情報、MISP等に関わる情報提供
・CMP/FEPに基づくIndividual Planの作成・実行
・Scientific Exchangeを介したUnmet Medical Needs、Data Gap等のInsight収集
・担当疾患領域に関わる論文、学会等の情報収集
・SL Listの構築および更新
・情報(Insight、論文情報、学会情報)の社内関連部署との共有
・アドバイザリーボード、Medical Education等メディカルイベントのサポート
【必要な知識・スキル・コンピテンシー】
Required
・科学的なデータを理解する基礎知識
・担当疾患領域に対する学習意欲
・メディカル戦略の理解と実行能力
・複雑な情報を明確かつ端的に説明することができる
・コミュニケーション能力
・チーム員としての協調性
・高い倫理観
Preferred
・担当疾患領域における基礎、臨床、疫学知識
【職務経験】
・2年以上の医療関係企業・アカデミアでの勤務経験。
【専攻・専門分野】
・医学・薬学・その他生命科学分野
【学歴・資格】
Required
・いずれかを有する方:修士号(Master)、博士号(Ph.D)もしくは医師、薬剤師、獣医師、歯科医師等
※今回の募集は、Specialist(Grade: 2)または、Sr. Specialist(Grade:3)で採用予定です。
※Manager職ではございません。
Required Skills:
Accountability, Accountability, Adaptability, Biomedical Sciences, Clinical Data Interpretation, Clinical Engagement, Clinical Immunology, Clinical Medicine, Clinical Sciences, Clinical Trial Methodology, Clinical Trial Support, Drug Registration, Emergency Care, Healthcare Education, Infectious Disease, Medical Care, Medical Communications, Medical Knowledge, Medical Marketing Strategy, Multiple Therapeutic Areas, Pharmaceutical Management, Pharmaceutical Medical Affairs, Pharmaceutical Sales, Pharmaceuticals Marketing, Pharmacology {+ 5 more}
Preferred Skills:
Current Employees apply HERE:
Current Contingent Workers apply HERE:
Search Firm Representatives Please Read Carefully Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
Regular
Relocation:
VISA Sponsorship:
Travel Requirements:
Flexible Work Arrangements:
Hybrid
Shift:
Valid Driving License:
Hazardous Material(s):
Job Posting End Date:
12/31/2026
A job posting is effective until 11: 59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs
About Merck

Merck
PublicMultinational pharmaceutical company.
10,001+
Employees
Rahway
Headquarters
Reviews
3.6
19 reviews
Work Life Balance
3.8
Compensation
3.2
Culture
3.0
Career
2.8
Management
2.5
60%
Recommend to a Friend
Pros
Large company with networking opportunities
Good work-life balance
Decent benefits and salary
Cons
Limited upward and lateral mobility
Slow promotion timeline
Favoritism in advancement
Salary Ranges
2,500 data points
Director
Director · Associate Director, D&A Strategy
1 reports
$176,890
total / year
Base
$153,800
Stock
-
Bonus
-
$176,890
$176,890
Interview Experience
20 interviews
Difficulty
2.9
/ 5
Duration
14-28 weeks
Offer Rate
25%
Experience
Positive 10%
Neutral 50%
Negative 40%
Interview Process
1
Application Review
2
Recruiter Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Decision
Common Questions
Technical Knowledge
Behavioral/STAR
Past Experience
Culture Fit
Case Study
News & Buzz
Merck stock jumps to $110 as MRK heads into a big earnings week - TechStock²
Source: TechStock²
News
·
5w ago
Merck & Co., Inc. (MRK) Joins BofA's "US 1 List" - Finviz
Source: Finviz
News
·
5w ago
Cantor Fitzgerald Sees Deal Activity and Pipeline Progress as Key for Merck’s (MRK) Next Phase - Insider Monkey
Source: Insider Monkey
News
·
5w ago
Federated Hermes Inc. Sells 307,109 Shares of Merck & Co., Inc. $MRK - MarketBeat
Source: MarketBeat
News
·
5w ago

